Page last updated: 2024-10-31

mianserin and Epilepsy

mianserin has been researched along with Epilepsy in 9 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Research Excerpts

ExcerptRelevanceReference
"To examine the effects of the noradrenergic and specific serotonergic antidepressant mirtazapine on motor cortex excitability in epilepsy patients with depression and in healthy controls, using transcranial magnetic stimulation (TMS)."7.73Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression. ( Gerschlager, W; Langosch, JM; Münchau, A; Orth, M; Rothwell, JC; Trimble, MR, 2005)
"To examine the effects of the noradrenergic and specific serotonergic antidepressant mirtazapine on motor cortex excitability in epilepsy patients with depression and in healthy controls, using transcranial magnetic stimulation (TMS)."3.73Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression. ( Gerschlager, W; Langosch, JM; Münchau, A; Orth, M; Rothwell, JC; Trimble, MR, 2005)
"On the average, seizures were observed at 40 mg/kg and were seen after desmethylimipramine (50 mg/kg), mianserin (30 mg/kg), amitriptyline (20 mg/kg), imipramine (40 mg/kg), maprotiline (40 mg/kg), and zimelidine (50 mg/kg)."1.27Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model. ( Bradford, D; Krijzer, F; Snelder, M, 1984)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19904 (44.44)18.7374
1990's2 (22.22)18.2507
2000's3 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Juckel, G2
Schüle, C1
Pogarell, O2
Rupp, D1
Laakmann, G1
Hegerl, U2
Münchau, A1
Langosch, JM1
Gerschlager, W1
Rothwell, JC1
Orth, M1
Trimble, MR1
Sterr, A1
Padberg, F1
Amann, B1
Mergl, R1
Mulert, C1
Krijzer, F1
Snelder, M1
Bradford, D1
Sedgwick, EM1
Edwards, JG1
Evans, L1
Lander, CM1
Mikhail, WI1
Koponen, H2
Honkonen, S2
Partanen, J2
Riekkinen, PJ2

Trials

1 trial available for mianserin and Epilepsy

ArticleYear
Mianserin, maprotiline and the electroencephalogram.
    British journal of clinical pharmacology, 1983, Volume: 15 Suppl 2

    Topics: Adult; Anthracenes; Dibenzazepines; Electroencephalography; Epilepsy; Female; Humans; Male; Maprotil

1983

Other Studies

8 other studies available for mianserin and Epilepsy

ArticleYear
Epileptiform EEG patterns induced by mirtazapine in both psychiatric patients and healthy volunteers.
    Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:4

    Topics: Adult; Antidepressive Agents; Electroencephalography; Epilepsy; Female; Humans; Mental Disorders; Mi

2003
Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression.
    Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:4

    Topics: Adult; Antidepressive Agents, Tricyclic; Arousal; Depressive Disorder, Major; Electric Stimulation;

2005
Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:2

    Topics: Adult; Amitriptyline; Antidepressive Agents; Cerebral Cortex; Citalopram; Cyclohexanols; Electroence

2006
Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model.
    Neuropsychobiology, 1984, Volume: 12, Issue:4

    Topics: Amitriptyline; Animals; Antidepressive Agents; Desipramine; Disease Models, Animal; Dose-Response Re

1984
Mianserin and epilepsy.
    The Medical journal of Australia, 1980, Oct-18, Volume: 2, Issue:8

    Topics: Adult; Depressive Disorder; Dibenzazepines; Epilepsy; Humans; Male; Mianserin; Phenytoin; Seizures

1980
Epileptogenic effect of mianserin.
    Lancet (London, England), 1979, Nov-03, Volume: 2, Issue:8149

    Topics: Adult; Convulsants; Dibenzazepines; Epilepsy; Female; Humans; Mianserin

1979
[Symptoms of Creutzfeldt-Jakob disease during mianserin therapy].
    Duodecim; laaketieteellinen aikakauskirja, 1991, Volume: 107, Issue:3

    Topics: Aged; Creutzfeldt-Jakob Syndrome; Depression; Epilepsy; Epilepsy, Tonic-Clonic; Female; Humans; Male

1991
Epileptic attack, delirium, and periodic complexes in the EEG during mianserin treatment.
    Journal of neurology, neurosurgery, and psychiatry, 1991, Volume: 54, Issue:4

    Topics: Aged; Creutzfeldt-Jakob Syndrome; Delirium; Depressive Disorder; Diagnosis, Differential; Electroenc

1991